insights_auto
Sebab ANW meningkat 2.78%?
Terokai Dengan Lebih Terperincichevron_right
ANW:FRA
Immuron Ltd
€0.018
arrow_upward
+2.78%(+0.00050) 1H
2 Okt, 10:00:00 PTG GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk ANW...
Buka
€0.02
Tinggi
€0.02
Rendah
€0.02
Permodalan Pasaran
8.65J
Purata volum
627.00
Volum
0.00
tgi 52 mgu
€0.04
rdh 52 mgu
€0.01
Bilangan pekerja
8
Buka
€0.02
Tinggi
€0.02
Rendah
€0.02
Permodalan Pasaran
8.65J
Purata volum
627.00
Volum
0.00
tgi 52 mgu
€0.04
rdh 52 mgu
€0.01
Bilangan pekerja
8
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
2 hari lalu
Dow naik 260 mata selepas data pekerjaan lemah mengangkat saham AS
Moomoo
·
49 minit lalu
The Next Generational AI Monopoly: Why Rezolve AI ($RZLV) is a Screaming Buy Before a 10x Repricing
Simply Wall Street
·
54 minit lalu
October 2026 Founder Led Stocks To Watch
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Perihal Immuron Ltd
CEO-
Pekerja8
Diasaskan1994
Ibu pejabatBlackburn North, Victoria, Australia
Sektor-
Laman webimmuron.com.au